Ohio State ethics and public health expert available to discuss coronavirus outbreak and the implications of quarantine, travel restrictions and other measures
Ohio State University
The first type of influenza virus we are exposed to in early childhood dictates our ability to fight the flu for the rest of our lives, according to a new study from a team of infectious disease researchers at McMaster University and Université de Montréal.
A new study led by Washington University School of Medicine in St. Louis offers a genetic road map detailing the similarities and differences in immune responses to TB across three species — mice, macaques and humans. According to the researchers, the insight into the immune pathways that are activated in diverse models of TB infection will serve as a valuable tool for scientists studying and working to eradicate the disease.
– Over the past year, at least seven children have died from diseases including influenza while being detained by the U.S. Department of Homeland Security’s Customs and Border Protection (CBP) agency. Infectious disease experts at the University of Maryland School of Medicine (UMSOM) called for protections like influenza vaccinations to prevent serious outbreaks.
The Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et al), published Jan. 29 in NEJM, reconfirms that screening high-risk patients greatly reduces lung cancer deaths. Regulators and physicians should act to ensure access to these lifesaving exams.
The study reveals a detailed epigenetic mechanism for how interleukin-1-beta, a common cytokine that helps fight infections during inflammation, plays a critical role in cancer metastasis.
High levels of CO2 in the body, due to chronic respiratory disorders, may exacerbate pancreatic cancer, making it more aggressive and resistant to therapy.
Experts in population mapping at the University of Southampton have identified cities and provinces within mainland China, and cities and countries worldwide, which are at high-risk from the spread of the 2019 Novel Coronavirus (2019-nCoV).
Experts from Johns Hopkins School of Nursing offer key thoughts for health professionals and citizens alike on how to prevent illness, while remaining ready to tackle an unfolding outbreak.
A groundbreaking tumor-highlighting technology—OTL38—enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible.
A virus spreading in China has the world on alert.
Infectious diseases could be detected, prevented and controlled thanks to a new £4m grant from the NIHR to the University of Warwick. Researchers will work with partners to develop the use of cutting edge genomics to protect public health.
Researchers from public health, medicine, engineering,
With news that the coronavirus called 2019-nCoV is capable of spreading from human to human, many are concerned about the possibility of a new pandemic, and that is not outside the realm of possibility, according to Jeff Hogan, a professor and infectious disease expert at the University of Georgia, who studied the SARS coronavirus extensively.
In one urban ED that sees approximately 12,000 pediatric patients a year, a team of emergency medicine physicians devised a model that would optimize resources, reduce length of stay dramatically, and increase patient satisfaction.
University of Chicago Medicine associate professor and infectious disease expert Dr. Emily Landon explains what public health officials know about new coronavirus virus from Wuhan, China and how to stay safe.
An infection prevention and control expert at Rutgers University discusses what is known about the new infectious disease and who is most at risk
Changes in the lung microbiome may help predict how well critically ill patients will respond to care, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The virus appears to be less dangerous than SARS, but there are still concerns of a wider outbreak in Asia.
A study in mice finds that a compound modeled on a protein found in bananas safely protects against multiple strains of the influenza virus, Ebola and coronaviruses.
Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for obstructive sleep apnea (OTA).
Researchers at Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins University School of Medicine have developed an integrated genomic approach that potentially could help physicians predict which patients with nonsmall cell lung cancer will respond to therapy with immune checkpoint inhibitors.
Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients. A multidisciplinary team of researchers from Children’s Hospital of Philadelphia (CHOP) redesigned the hospital’s standard treatment for the infection and reduced albuterol use without compromising care.
Prominent lung cancer expert Karen L. Reckamp, MD, MS, has been selected to be director of the Division of Medical Oncology at Cedars-Sinai Cancer. Reckamp also will serve as medical oncology director of the Women's Guild Lung Institute in Cedars-Sinai's Department of Medicine and associate director for Clinical Research at Cedars-Sinai Cancer.
A team of researchers from the National University of Singapore has developed a personalised assessment tool which can detect the incidence of cancer, predict patient survivability and determine patient suitability for immunotherapy cancer treatment.
Sharon Wright,MD, MPH, BIDMC’s Senior Medical Director of Infection Control/Hospital Epidemiology at Beth Israel Deaconess Medical Center shares everything you need to know about the flu.
A new artificial model of premature infants will make possible experiments that are expected to reduce injury to infants on respirators.
A new Cleveland Clinic study has uncovered a genetic anomaly associated with poor response to a common asthma treatment. The findings, published in Proceedings of the National Academy of Sciences, showed that asthmatic patients with the gene variant are less likely to respond to glucocorticoids and often develop severe asthma.
Philadelphia, the City of Brotherly Love, will play host to the ATS 2020 International Conference, the biggest gathering of scientists and clinicians in pulmonary, critical care, and sleep medicine.
Weight loss in obese patients with obstructive sleep apnea (OSA) appears to improve sleep apnea primarily by reducing tongue fat, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.
Thirty-three cases of the asbestos-related lung cancer mesothelioma draw attention to talcum powder as a non-occupational source of exposure to asbestos, according to a study in the January Journal of Occupational and Environmental Medicine.
The ATS Foundation Research Program/Foundation for Sarcoidosis has awarded Nicholas Arger, MD, of the University of California, San Francisco a $80,000 Foundation Partner grant. The ATS Foundation Partner Grant provides crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
The winter cold and flu season may try to knock out your new year’s plans to get or stay healthy, but the good news is you can fight back.
Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.
Dana-Farber Cancer Institute will create the Chen-Huang Center for EGFR (epidermal growth factor receptor) Mutant Lung Cancers to stimulate research, promote clinical trials, and strengthen the Institute’s capabilities for studying and treating lung cancer.